Nanoparticles target psoriasis genes, aiming to treat 190 million people worldwide

MedicalXpress | июн 08, 2026

A technological platform developed by Brazilian researchers could revolutionize the treatment of skin diseases such as psoriasis and vitiligo. The group, affiliated with the NanoGeneSkin laboratory at the University of São Paulo (USP) in Ribeirão Preto, is developing nanoparticles capable of delivering therapeutic RNA molecules directly to skin cells. These nanoparticles can precisely silence the genes responsible for chronic inflammation at the molecular level.